Leniobio
Düsseldorf, DE · Founded 2016 · 48 employees on LinkedIn · 1 known investors
LenioBio develops ALiCE, a cell-free protein expression platform that accelerates the discovery, development, and manufacturing of proteins and biologics for pharmaceutical and vaccine manufacturers. The platform addresses production bottlenecks in drug and vaccine development by enabling faster, scalable biomanufacturing beyond traditional cell-based approaches.
Founders & leadership
Leniobio was founded in 2016 by Remberto Martis.
Investors · 1
Frequently asked questions
- What does Leniobio do?
- LenioBio develops ALiCE, a cell-free protein expression platform that accelerates the discovery, development, and manufacturing of proteins and biologics for pharmaceutical and vaccine manufacturers. The platform addresses production bottlenecks in drug and vaccine development by enabling faster, scalable biomanufacturing beyond traditional cell-based approaches.
- Who founded Leniobio?
- Leniobio was founded by Remberto Martis in 2016.
- Who are Leniobio's investors?
- Leniobio's investors include Bridford Investments (Bridford Group).
- Where is Leniobio headquartered?
- Leniobio is headquartered in Düsseldorf, DE.